CTI CAPITAL
CTI Capital is a venture capital fund that invests in development-stage, Canadian life sciences companies.
CTI CAPITAL
Industry:
Biotechnology Pharmaceutical Venture Capital
Founded:
1987-01-01
Status:
Active
Technology used in webpage:
SPF Domain Not Resolving Euro Microsoft Exchange Online Office 365 Mail Google Maps GoDaddy DNS Google Maps API GoDaddy
Current Advisors List
![]()
Current Employees Featured



![]()

![]()
![]()


Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-18 | Wattio | CTI Capital investment in Venture Round - Wattio | 170 K EUR |
| 2014-07-14 | Xagenic | CTI Capital investment in Series B - Xagenic | 25.5 M USD |
| 2012-01-30 | Xagenic | CTI Capital investment in Series A - Xagenic | 10 M USD |
| 2011-09-22 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 8.1 M USD |
| 2009-08-10 | Enobia Pharma | CTI Capital investment in Series C - Enobia Pharma | 50 M USD |
| 2009-06-29 | Zymeworks | CTI Capital investment in Venture Round - Zymeworks | 3.2 M USD |
| 2000-03-31 | BeXcom | CTI Capital investment in Venture Round - BeXcom | 75 M USD |